Endocrine Metabolic & Immune Disorders - Drug Targets

译名:内分泌、代谢与免疫疾病-药物靶点

Endocrine Metabolic & Immune Disorders-Drug Targets

SCIEJCR Q3中科院4区

1-3

2026

影响因子区间

平台估算

投稿周期

56%

2025

中国作者发文占比

3150 CHF

费用说明

收费

期刊简介:Aims & ScopeThis journal is devoted to timely reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbioma composition are welcome.

【译文】旨在及时回顾和发表内分泌、代谢和免疫疾病领域的实验和临床研究。特别强调对天然、合成和基因工程药物在增强或损害内分泌、代谢和免疫参数和功能方面的体液和细胞靶点的关注。此外,欢迎有关食物成分和/或营养补充剂对内分泌-代谢-免疫轴和微生物组组成的影响的课题。

出版社
Bentham Science Publishers
语言
English
学科
医学
ISSN
1871-5303
eISSN
2212-3873
出版频率
双月刊
创刊年份
2010
投稿网址
http://bsp-cms.eurekaselect.com/index.php/CDTIEMD
最近更新
2026-04-02 18:16:40
Endocrine Metabolic & Immune Disorders - Drug Targets

指标当前值近三年趋势
JCR分区Q3
暂无
中科院分区4区
暂无
影响因子区间1-3
暂无